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Abstract
Aims: This study aimed to examine the effect of high fat diet (HFD) to modulate brain dysfunction, and
understand the linkages between obesity, metabolic disturbances and the brain oxidative stress (BOS) dysfunction
and modulation with hydroxyl citric acid of G. Cambogia.
Methods: Rats were divided into 3 groups; 1
st control, maintained on standard normal rat chow diet, 2
nd HFD,
maintained on high fat diet along 12 week and 3
rd HFD+G, administered G. Cambogia for 4 weeks and each group
include 8 rats. Blood, brain and abdominal fat were collected for biochemical measurements.
Results: HFD group showed significant increase in energy intake, final BW and BW gain. Also significant increase in
weight of abdominal fat in HFD group. HFD induce metabolic disturbance through increasing the lipid profile (LDL,
TG, TC), gGT and a-amylase activity, uric acid level and hyperglycemia, while decreasing creatine kinase (CK)
activity.
These changes associated with lowering in brain nitric oxide (NO) level and rising in serum butyrylcholinesterase
(BChE), brain catalase activity and MDA levels as oxidative stress markers. These alterations improved by G.
Cambogia that decrease BOS and increased NO level.
Conclusions: Rats fed HFD showed, metabolic disturbances produce hyperglycemia, hypertriglyceridemia,
hypercholesterolemia and increased LDL associated with increased BOS. Involvement of BuChE, NO and oxidative
stress associated with metabolic disturbances in the pathophysiological progression in brain, suggesting association
between obesity, metabolic disorders and brain alteration while, using G. Cambogia, ameliorate the damaging
effects of the HFD via lowering feed intake and BOS.
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1- Introduction
The brain is exceptionally susceptible to oxidative stress
that may be caused by high fat diet and xenobiotics
such as ethanol. HFD and alcohol metabolism is accom-
panied by enhanced free radicals formation and a
decrease in antioxidant abilities. Prolonged HFD pro-
motes a variety of morbidity factors although experi-
mental evidence for short-term western diet (WD)
mediating brain dysfunction remains to be elucidated.
The prevalence of central obesity among Egyptian adults
was 24.1% and 28.7% based on the waist circumference
and waist-to-hip ratio indicators respectively [1].
It has been shown that the disturbances originated by
high-fat feeding closely resemble the metabolic distur-
bances observed in humans [2]. Regardless of the
remarkable progress which has been made in our under-
standing of dietary fat and obesity/type 2 diabetes
(T2DM) with using HFD [3], it is important to point
out that relatively little is currently available in regards
to the study of HFDs and brain function and homeosta-
sis, they have an obvious limitation in the study of brain
dysfunction. Thus, HFD-induced models of metabolic
dysfunction should be considered the best option for
* Correspondence: kaamin10@yahoo.com
1Biochemistry Dept, Faculty of Vete. Medicine, Beni-Suef University, Beni-Suef,
Egypt
Full list of author information is available at the end of the article
Amin et al. Lipids in Health and Disease 2011, 10:74
http://www.lipidworld.com/content/10/1/74
© 2011 Amin et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.studying the effects of metabolic dysfunction on brain
function.
The pathogenesis of the relationship of obesity, dia-
betes and neuropathy still far from observable, partly
due to the lack of a suitable animal model that
mimics human neuronal disease in T2DM, therefore
we aimed to develop rodent model of obesity. There
was a lack of records and research about the effect of
obesity on brain pathophysiology and biochemical
relationship. The probable for hydroxy citric acid
(HCA) extraction of G. Cambogia to counteract the
expected metabolic disturbance and brain dysfunc-
tion effects of obesity is important and merit
investigation.
BChE is a serine hydrolase biochemically related to
the cholinergic enzyme acetylcholinesterase. It is capable
of hydrolyzing esters of choline. BChE has unique enzy-
matic properties and is widely distributed in the nervous
system, raising the possibility of its involvement in
neural function [4].
Adipose tissue has long been considered as a mere
energy store but is increasingly appreciated for its roles
in participating in several physiological and biochemical
events such as inflammation, angiogenesis, hypertension,
and vascular homeostasis. Moreover, the adipose tissue
synthesizes and secretes a large number of factors col-
lectively termed ‘adipokines’ which characterized for
their role in influencing energy homeostasis and feeding
behavior. However, an increasing number of studies
have identified that adipokines may play a role in med-
iating long-term potentiation, neuroprotection, and neu-
roinflammation [5] and [6].
A major role for adipose tissue (adipocytes) is to
sequester and store circulating lipid, which protects
other cells and tissues in the body from the cytotoxic
effects of free fatty acids in the circulation. Failure of
adipocytes to effectively remove FFA from the circula-
tion contributes to a variety of health complications
including atherosclerosis, and ultimately the develop-
ment of metabolic syndrome. Conversely, the deposition
of adipose/lipid into muscle, liver, or bone marrow is
known to promote not only metabolic syndrome but
localized tissue dysfunction [7] which is the case with
brain. Therefore, it is clear that adipocytes perform
essential functions for the overall well being of indivi-
duals, but it is equally clear that adipose in the incorrect
places or in excessive quantity also negatively impacts
the health of an individual.
An increasing number of individuals regularly con-
sume a diet high in fat, with HFD consumption known
to be sufficient to promote metabolic dysfunction,
although the links between high-fat diet consumption,
brain oxidative and aging are now beginning to be
elucidated.
Therefore the aim of this study was to develop rodent
model of obesity by HFD and determine the metabolic
disturbances compared to control diet and record the
effect of obesity on brain and its effect on antioxidant
defense system. Also biochemical changes in blood and
tissue of rat and treatment of the affected group by G.
Cambogia. Moreover, analysis of serum BChE activity in
experimentally developed obesity and demonstrate the
mechanisms that link obesity with altered brain function
and propose future directions to be taken for addressing
obesity oxidative stress and Alzheimer’s disease.
2-Material and methods
Material
1- Diet
Two types of diets, control rat chow diet and special
diet high in fat (35%) were used for induction of obesity
in rats.
1
st Normal rat chow diet The standard normal rat
chow consists of concentrate (350 gm), corn (600 gm),
calcium carbonate, dicalcium phosphate, sodium chlor-
ide magnesium oxide and vitamins (50 gm). Standard
normal rat diet composed of 65% carbohydrates (60%
starch+5% sucrose), crude protein 20%, fat 5%, vitamins
and minerals 5%, fibers 5%, metabolic energy of this diet
is 2813 Kcal/Kg with 8% from fat.
2
nd the high fat diet HFD composed of 300 gm concen-
trates, 350 corn, 300 gm beef tallow, 50 gm vitamins,
minerals and fibers according to (Kim et al. [8]. Calcula-
tions of high fat diet were 40% carbohydrate (starch
35%, 5% sucrose), 20% crude protein, 35% fat, 5% vita-
mins and minerals and fibers. Metabolic energy of this
diet is 5130 Kcal/kg with 61% of this energy from fat.
2- Experimental animals
The present study carried out on male Wister rat, (100-
130 gm BW) 8 Wks age. They were purchased from
Helwan town, Cairo, Egypt.
Rats were kept under observation for one week before
onset of experiment to be acclimatized and housed indi-
vidually in metal cages at room temperature 37°C, less
than 12 hrs light/dark cycle in the laboratory of bio-
chemistry in Faculty of Veterinary Medicine-Beni Suef
University during the period of research. Water and spe-
cial diet were allowed to rats in free access. Body
weights were recorded weekly.
3-Drugs for treatment
G. Cambogia is potent antiobesity drugs, the active prin-
ciple is hydroxy citric acid (1,2-Dihydroxy-1, 2, 3-propa-
netricarboxylic acid) which used by dissolving one
capsule in 10 ml D.W, each capsule containing 500 mg.
G. Cambogia purchased from the EVA Pharm as a
source of HCA.
Oral administration of 50 mg/rat daily dose was used
according to the method described by Ohia et al. [9].
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did not affect weight gain. The drug was given to rat by
developed stomach tube and given slowly to rat
stomach.
Methods
This experimental research was approved by the Com-
mittee of Scientific Ethics at Beni Suef University,
faculty of veterinary medicine and consistent with its
guidelines.
1-Experimental design and animal grouping
Our experiments proceed for 12 week and include
induction and treatment period and the whole number
of rats was 24.
Induction period began from 1
st to 8
th wk; it was the
period of induction of obesity by feeding rats with HFD.
The animals divided into 2 groups control and HFD
groups. Control group, maintained on standard normal
rat chow diet along the all period of experiment (12 wk)
and include 8 rats, while HFD group was maintained on
high fat diet. Treatment period start form 8-12
th wk
during which HFD group continued on high fat diet and
(HFD+G) treated group maintained on high fat diet to 4
wks (8 rats) with administration of G. Cambogia treat-
ment at dose of 50 mg/rat/day by stomach tube.
Calculation of energy intake of consumed diet and
body weight Metabolic energy of standard rat chow and
high fat diet were 2813 and 5130 Kcal/kg respectively.
The average energy intake of consumed diet was calcu-
lating by multiplying the average consumed diet by
2.813 and 5.130 respectively according to consumed diet
[10]. BW was measured every week.
2 -Sampling and tissue preparation
Blood sampling Blood samples were collected from med-
ial canthus of the eye, via microhematocrit capillary tube
at fasting state. The blood samples were collected in dry
glass centrifuge tubes, allowed to coagulate at room tem-
perature and centrifuged at 3500 rpm for 15 minutes for
separation of serum. The clear, non-hemolysed superna-
tant sera were separated using clean dry disposable plastic
syringes and stored at -20°C for subsequent biochemical
measurements. Sodium fluoride used as anticoagulant for
measuring of glucose in another blood sample.
Tissue sampling At the end of experiment, rats were
sacrificed by decapitation and abdominal incision was
immediately done after taking of blood sample for obtain-
ing of brain and abdominal adipose tissues. Brain was
taken and washed by saline, dried by filter paper and
homogenization of 0.5 gm of this tissue was done for tissue
biochemical analysis of catalase, MDA and nitric oxide.
3- Biochemical assays of serum and tissue
Serum was analyzed for total cholesterol, triglycerides
and HDL levels. Also CK, gGT and a-amylase, BChE
activity were measured colorimetrically using kits
purchased from Bio-diagnostic (Cairo- Egypt). While
blood uric acid and glucose level were estimated using
Stanbio Laboratory USA Kits. Brain malondealdehyde
(MDA) level was measured, as described by Mihara and
Uchiyama [11], brain catalase (CAT) activity was deter-
mined according to the procedure of Cohen et al. [12]
and brain NO according to Miranda et al., [13].
Statistical analysis
D a t aw e r eo f f e r e da sm e a n±S E Ma n dw e r ea n a l y z e d
using one-way analysis of variance (ANOVA) followed
by Tukey-Kramer methods for post-hoc analysis. A
value of p < 0.05 was considered statistically significant.
Graph Pad Prism 5 software (San Diego, CA, USA) was
used for statistical analysis.
3. Results
3.1. Changes of BW, abdominal fat and energy intake
during HFD and treatment
In this study, final BW, BW gains (Figure 1) and energy
intake (Figure 2) was significantly increased accompa-
nied with significant increase in abdominal adipose tis-
sue (Table 1) in HFD compared with control group. G.
Cambogia treatment result in decrease BW, energy
intake and adipose tissues in relation to HFD group.
3.2. Effect of HFD and G. Cambogia treatments on
metabolic parameters
Table (1) showed decrease in CK, while significant
increase in gGT, a-amylase, BCHE activities. Moreover
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Figure 1 Effect of initial, final and gain of body weight (gm) in
the different groups of experiment. In this study, final BW, BW
gains (Figure 1) was significantly increased in HFD compared with
control group. G. Cambogia treatment result in decrease BW, energy
intake and adipose tissues in relation to HFD group.
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Page 3 of 11uric acid level increases significantly and hyperglycemia
occurs in HFD group relative to control. Some of these
changes were significantly rearranged in HFD+G com-
pared with HFD group ≤ 0.05.
F i g u r e( 3 )d e m o n s t r a t e ds i g n i f i c a n ti n c r e a s ei ns e r u m
lipid profile TC, TG and LDL level due to ingestion of
HFD compared with control and G. Cambogia extract
improve these changes.
3.3. Effects of HFD and treatment on BOS (MDA and
catalase activity)
In brain tissues, MDA level and catalase activities were
significantly increased in HFD compared with control
g r o u pa n dt r e a t m e n tw i t hG. Cambogia ameliorated
these changes (Table 2).
3.4. Correlation coefficient between parameters in
different groups of rats
Significant positive correlation was detected between
BChE activity and serum TG level (P < 0.03 and r =
0.96), TC (P < 0.001 and r = 0.99) and abdominal fat
weight (P < 0.007 and r = 0.99), while serum BChE
activity had a negative correlation with brain NO con-
centration (P < 0.04 and r = -0.96) (Table 3).
Brain MDA positively correlated with TG (P < 0.05
and r = 0.95), blood glucose (P < 0.007 and r = 0.99),
final BW (P < 0.03 and r = 0.91) and brain catalase (P <
0.005 and r = 0.97) while, negatively correlated with
brain NO (P < 0.05 and r = -0.95). There were negative
correlation between blood glucose and brain NO (P <
0
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Figure 2 Means of total energy intake k/calory in total period
of experiment (3 months) in different groups of rats. Figure (2)
illustrated significant increase in energy intake in HFD compared
with control. Values are statistically analyzed by one way ANOVA.
Column have different letters indicate significant variation at (P ≤
0.05), while the same letters indicate non significant variation.
Table 1 Changes in blood metabolic parameters CK, gGT,
a-amylase, BCHE activity, Uric acid, abdominal fat and
glucose level in control, HFD and HFD+G in rat.
Groups Parameters Control HFD HFD+ G
CK(U/L) 70.0 ± 4.2
a 63.0 ± 2.2
a 69.0 ± 4.8
a
gGT (U/L) 30.0 ± 2.7
a 65.0 ± 6.2
b 33.0 ± 3.5
a
a-amylase (U/L) 93.0 ± 4.8
a 150.0 ± 13
b 110.0 ± 9.6
c
BCHE (U/L) 260 ± 22
a 500.0 ± 39
b 300.0 ± 21
a
Uric Acid 3.2 ± 0.13
a 6.3 ± 0.32
b 4.1 ± 0.16
a
Abdominal fat (g) 4.98 ± 0.61
a 9.2 ± 0.71
b 5.0 ± 0.64
c
Glucose (mg/dl) 59.0 ± 1.6
a 111.0 ± 4.1
b 91.0 ± 3.9
c
Table (1) showed decreased activity of CK, while significant increase in gGT, a-
amylase, BCHE activities. Moreover significant increase in abdominal adipose
tissue, uric acid level increases significantly and hyperglycemia occur in HFD
group relative to control. Some of these changes were significantly rearranged
in HFD+G compared with HFD group ≤ 0.05.
Each value is the mean ± SEM. Means have different superscript letters indicate
significant variation at (P ≤ 0.05), while the same letters indicate non significant
variation
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Figure 3 Effect of lipid profile TC, TG, LDL and HDL (gm/dl) in
the different groups of experiment. Figure (3) demonstrated
significant increase in serum lipid profile TC, TG and LDL level due
to ingestion of HFD compared with control while, G. Cambogia
extract improve these changes.
Table 2 Means of brain catalase, MDA and Nitric oxide
levels in different groups of rats (3 months)
Groups Parameters Control HFD HFD+G
Brain Catalase (U/gm) 5.1 ± 0.69
a 12.2 ± 0.63
b 10.3 ± 0.32
b
Brain MDA (nmol/g) 2.6 ± 0.24a 5.7 ± 0.31
b 4.9 ± 0.61
c
Brain Nitric oxide 1.3 ± 0.08
a 0.8 ± 0.11
b 1.1 ± 0.12
ab
In brain tissues, MDA level and catalase activities were significantly increased
in HFD compared with control group and treatment with G. Cambogia
ameliorated these changes (Table 2).
Values are statically analyzed by one way ANOVA and reported as means ± SEM.
Means have different letters indicate significant variation at (P ≤ 0.05), while the
same letters indicate non significant variation
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Page 4 of 110.024 and r = -0.9) (Table 3) in rats group. Also the data
showed negative correlation between brain NO and
MDA levels (P = 0.05 and r = -0.95) (Table 3).
4-Discussion
4-1- Role of HFD and treatment in BW and abdominal fat
Our data showed that there were significant increase in
BW and abdominal fat in HFD compared to control
group (Figure 1 and table 1). This may due to increase
feed and caloric intake.
Consumption of the G. Cambogia extract effectively
lowered the BW, visceral fat accumulation and improv-
ing dyslipidemia in HFD group, probably by modulating
multiple genes associated with adipogenesis, such as adi-
pocyte protein aP2 and sterol regulatory element-bind-
ing factor [8].
HCA, an active constituent of the G. Cambogia,
diminish food utilization in rodent models of obesity
may be by diverting carbohydrates and fatty acids that
would have become fat in the liver into hepatic glyco-
gen. This metabolic change may send a signal to the
brain that result in a reduced appetite, so reduce BW
which may be due to HCA combined effects on the
metabolic and serotonin pathways [14].
We can conclude that increase feed intake due to
HFD significantly amplify body weight and abdominal
fat while treatment with GC a m b o g i adecline BW and
abdominal fat.
4.2. Metabolic disturbance of dyslipidemia and brain
dysfunction in HFD and treatment groups
Currently there are believed to be 41 million Americans
that can be considered to be prediabetic, with the pre-
diabetic state associated with a progressive development
of multiple metabolic disturbances which precedes the
irreversible stage of diabetes and importantly can even
occur independent of the development of diabetes [15].
The current results indicated a significant increases in
serum lipid profile (TC, TG and LDL levels) in HFD
compared to control (Figure 3) resulting in dyslipidemia
which is a common disturbance associated with HFD
consumption.
The link between dyslipidemia and having a higher risk
of cognitive impairment or dementia is controversial.
Reduced levels of high-density lipoprotein cholesterol have
been reported in some cases of dementia but not all cases
of dementia [16].
Concerning records for HFD exacerbating brain the
current experiment showed significant increases in
energy intake in HFD compared to control diet (Figure
2). Moreover rats fed HFD had both hyperglycemia and
hypertriglyceridemia. Various forms of dietetic fat differ-
entially change the expression of neuropeptide genes
involved in energy homeostasis [17].
HFD consumption is thought to induce changes not
only in energy metabolism but also in brain function
which may be due to disturbances of ATP in brain cells
as the main cause of various brain disorders. HFD con-
sumption and the presence of metabolic dysfunction are
sufficient to exacerbate brain aging, promoting the
development of cognitive alterations including dementia
[18]. Moreover, fatty acid overload or metabolic dys-
function might impair neural control of energy homeos-
tasis and contribute to obesity and/or T2DM in
predisposed subjects [19].
Biochemically, HFD-induced disturbances in metabo-
lism resulting in increase in the flux of free fatty acids
(FFA) into a variety of tissues (liver, pancreas and
Table 3 Correlation coeffecient between parameters in different groups of rats
BChE TG TC Glucose Abdomin Fat Final BW Brain Catalase Brain NO
BChE —— P < 0.033
r = 0.96
P < 0.001
r = 0.99
NS P < 0.007
r = 0. 99
NS NS P < 0.04
r = -0. 96
TG ——— ____ P < 0.048
r = 0.95
P < 0.02
r = 0.97
P < 0.021
r = 0.98
————— P < 0.04
r = 0.90
P < 0.004
r = -0.99
Brain MDA NS P < 0.05
r = 0.95
NS P < 0.007
r = 0.99
NS P < 0.03
r = 0.91
P < 0.005
r = 0.97
P < 0.05
r = -0.95
Brain Catalase NS ——— NS P < 0.006
r = 0.99
NS P < 0.03
r = 0.91
____ P < 0.04
r = -0.95
Brain NO ———— ———— P < 0.05
r = -0.94
P < 0.024
r = -0.97
P < 0.02
r = -0.98
NS P < 0.05
r = -0.94
____
Final BW NS P < 0.008
r = 0.99
NS P < 0.013
r = 0.98
P < 0.035
r = 0.96
——— P < 0.03
r = 0.97
P < 0.002
r = -0. 99
r = Value of correlation coefficient. P ≤ 0.05 indicate significant variation.
Significant positive correlation was detected between BChE activity and serum TG level (P < 0.03 and r = 0.96), TC (P < 0.001 and r = 0.99) and abdominal fat
weight (P < 0.007 and r = 0.99), while serum BChE activity had a negative correlation with Brain NO concentration (P < 0.04 and r = -0.96) (Table 3).
Brain MDA positively correlated with TG (P < 0.05 and r = 0.95), blood glucose (P < 0.007 and r = 0.99) and final BW (P < 0.03 and r = 0.91) while, negatively
correlated with NO (P < 0.05 and r = -0.95). There were negative correlation between blood glucose and brain NO (P < 0.024 and r = -0.9) (Table 3) in rats group.
Also the data showed negative correlation between brain NO and MDA levels (P = 0.05 and r = -0.95), (Table 3).
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tion of triglycerides into these tissues. Elevations in FFA
promote metabolic disturbances by impairing the ability
of cells to store glucose as glycogen and to respond to
insulin, which cumulatively are capable of promoting
the development of diabetes. Cumulatively, these events
lead to hyperinsulinemia and hyperglycemia (Table 1)
due to impaired insulin-mediated regulation of glucose
levels.
HFD consumption probably mediates brain distur-
bances may be via reducing the ability of the brain to
successfully respond to stressors (as is observed in other
tissues). A decreased capacity to repair or replace
damaged brain system may play a causal role in promot-
ing both neuropathology and neurobehavioral deficits
[20].
For example, decreased trophic factor support or vas-
cular support in response to a western diet as reported
in non-CNS tissues would be expected to potentially
contribute to the development of neuropathology and
dementia.
Multiple metabolic defectsi nT 2 D Md i r e c t l yi n j u r e
dorsal root ganglia neurons through different mechan-
isms that all result in oxidative stress. Dyslipidemia
l e a d st oh i g hl e v e l so fo x L D L st h a tm a yi n j u r ed o r s a l
r o o tg a n g l i an e u r o n sv i aL O X - 1a n dc o n t r i b u t et ot h e
development of diabetic neuropathy [21].
The indication for HFD promoting brain pathogenesis
could be summarized as; HFD-induced metabolic dys-
function promotes cognitive alterations and dementia
[22].
Studies carried out in rats in agreement with our bio-
chemical evidence, have shown that, a diet high in satu-
rated fatty acids can impair learning and memory
functions. In addition, the strong relationship between
obesity and cognitive impairment found in animals [23].
The serum concentrations of cholesterol and triglycer-
ide were significantly lower in animals that were given
the G. Cambogia than in the HFD control group. These
results may attribute to the effect of HCA that inhibit
the lipogenesis catalyzed by ATP citrate-lyase in the
liver and peripheral tissues; also it prevents the produc-
tion of acetyl-CoA and, subsequently, malonyl-CoA [24].
4.3. Changes of CK, amylase, gGT, uric acid and glucose
as indicators for metabolic disturbances in HFD and
treatment groups
Activity of creatine kinase (Table 1) was decreased while
an increase in lipid peroxidation (MDA) was observed
in HFD compared to control group.
Creatine kinase plays a key role in energy metabolism
of nervous tissue and might be one of the targets for
reactive oxygen species (ROS) [25]. HFD was shown to
produce an increase of serum CK activity in rats [26].
Moreover obesity is associated with an increase in the
percentage of fast twitch, oxidative-glycolytic muscle
fibers that use glucose as an energy substrate. Therefore,
an increase of CK under HFD conditions may reflect an
increase of glycolytic enzyme activity.
Pancreatic a-amylase level was reduced in HFD com-
pared to control (Table 1). We suggest that the bio-
chemical assay of pancreatic enzymes might be of value
in determining the severity of obesity and could be used
as a parameter in evaluating the response to treatment
[27].
gGT activity was higher in HFD compared with con-
trols (Table 1) this result associated with metabolic
abnormalities and correlated with metabolic syndrome
individual components including, hyperglycemia and
insulin resistance [28]. Xu et al., [29] recorded that
there was significant and independent associations of
gGT and ALT with metabolic syndrome and there are
positive associations between serum gGT and other con-
current metabolic abnormalities which resulting in brain
dysfunction.
Risk for the metabolic disturbances components
increased as the baseline gGT activity increased, indicat-
ing that high gGT activity predicted future development
of metabolic disturbances.
Uric acid has been known to exert neuroprotective
effects by acting as a free radical scavenger; however,
several observational studies indicated that high levels of
serum uric acid increased the risk of cardiovascular
events or stroke. It was sought to determine whether
increased levels of uric acid are associated with the pre-
sence of silent brain infarction (SBI) [30]. The current
data showed elevation in uric acid in HFD associated
with hypertriglyceridemia and hypercholesterolemia sug-
gesting that an increased level of uric acid may be a risk
factor for the presence of SBI. So serum uric acid level
might be a good serum marker of underlying SBI or
future stroke.
High levels of urate have been associated with dia-
betes, with increased burden of cerebral ischemic
pathology, increased risk of mild cognitive dysfunction
and ischemic white matter lesions, which are risk factors
for cognitive impairment [31].
Impaired antioxidant defenses are implicated in neuro-
degenerative disease. The blood levels of uric acid, a
water-soluble antioxidant, are elevated in HFD may be
to compensate the oxidative stress that may occur and
act as response to the metabolic disturbances and its
level may be modified by the HFD.
Recently Wu et al., [32] study the association of
hyperuricemia (HUA) with metabolic disorders and
identify the risk factors of HUA and concluded a several
risk factors contribute to the occurrence of elevated
serum uric acid in T2DM, and metabolic disorders and
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Also patients with HUA had significantly higher inci-
dences of carotid atherosclerosis, cerebral infarction and
diabetic nephropathy than those with normal uric acid
level.
Insulin has been suggested to play important roles in
regulating memory, so any disturbance in insulin signal-
ing would be expected to have a negative impact on
memory [33]. Some studies have demonstrated that
HFDs were able to increase amyloid beta peptide (Ab)
levels and Ab-neuropathy in brains of mice exhibiting
Alzheimer’s disease pathology.
Recent studies suggested that hyperinsulinemia and
insulin resistance are linked to Alzheimer’s disease (AD)
and the increased amyloid beta-peptide (Abeta) in the
brain of HFD-fed mice is associated with reduced brain-
derived neurotrophic factor expression, which led to
abnormal feeding behavior and increased food intake,
resulting in obesity and insulin resistance in these ani-
mals, so experimental evidence suggests that alterations
in glucose and insulin metabolism may influence the
onset of AD through their influence on the synthesis
and degradation of Ab peptides [34].
One possible mechanism by which obesity may
increase the risk of stroke is via an alteration in cerebral
perfusion. Cerebral perfusion is regulated through active
constrictor and dilator mechanisms and by the physical
properties of the cerebral vasculature.
The changes of biochemical markers of obesity as
abdominal obesity, high BW and high caloric intake
(Figure 1, 2) associated with hypertriglyceridemia,
hypercholesterolemia, high LDL (Figure 3), high gGT,
hyperuricemia and hyperglycemia (Table 1), represent-
ing metabolic disturbances that consider a pre-diabetic
state which spot that harmful changes in metabolism
can predispose and predict T2DM.
4-4- Role of BChE activity in HFD and treatment groups
A significant increase in serum BChE activity in HFD was
observed when compared with the control group (Table
1). These findings agree with recent studies which
revealed elevated serum and tissue BChE actvity in obe-
sity, T2DM and Alzheimer’s disease. Acetylcholine (ACh)
has antiinflammatory action; hence elevated BChE
resulted in reduction in acetylcholine level that could
trigger the onset of low grade of systemic inflammation
seen in T2DM and Alzheimer’s disease [35] and [36].
Significant positive correlation was detected between
BChE activity and serum triglyceride levels (P < 0.03 and r
= 0.96), TC (P < 0.001 and r = 0.99) and indicators of
abdominal fat obesity (P < 0.007 and r = 0.99), while
serum BChE activity had a negative correlation with brain
NO concentration (P < 0.04 and r = -0.96) (Table 3).
These findings are important predictors of BChE
activity and suggested an involvement of BChE in the
pathophysiological process constituting the metabolic
syndrome. Whether elevated BChE activity precedes or
follows the development of risk factors is not known.
The opinion that obesity influence CNS had been
raised and there are link between adiposity and
increased risk of Alzheimer disease. Moreover there
were relation between insulin resistance, adiposity and
Alzheimer due to insulin advanced product of glycosyla-
tion, cerebral vascular disease and product of adipose
tissue [37].
Serum activity of the BChE are affected by dietary fat,
obesity, hyperlipidemia and diabetes mellitus. Similarly,
diabetes mellitus has been shown to alter the levels of
the enzyme. BchE, which can affect cell membrane oxi-
dative stress and fluidity, is structurally homologous to
lipase [38]. However other studies have suggested BchE
m a yn o th a v ead i r e c tp a t h o p h y s i o l o g i c a lr o l ei nt h e
development of metabolic syndrome, but may be consid-
ered as secondary markers for this syndrome in obese
individuals [39].
In consonance with other studies, BChE activity was
related to changes in serum lipids profile; however there
was a relationship to serum triglycerides and serum cho-
lesterol in our study. BChE activity could also be used to
select the drug for treatment of hypertriglyceridemia in
T2DM. Similarly diabetes was one of the risk factors for
coronary artery disease that independently correlated
with BchE activity [36].
High BChE activity in overweight rats, decrease the
vasodialting effect of acetylcholine via its hydrolysis and
associated with lowering the brain NO level causing
vasoconstriction of brain blood vessels rendering it sus-
ceptible to dysfunction. So th i si st h ef i r s ta n dan o v e l
data that explore the role of BChE activity and brain
NO associated with oxidative stress in brain dysfunction
of long term HFD ingestion.
The effects of G. Cambogia on impaired ACh-stimu-
lated vasodilation through restoring the brain NO level
and decrease brain catalase and MDA compared to the
HFD support the hypothesis that oxidative stress contri-
butes to brain endothelial dysfunction in obesity.
In particular, recent confirmation indicates that along
with acetylcholinesterase, BChE catalyzes the hydrolysis
of acetylcholine, and thus serves as a co-regulator of
cholinergic transmission. BChE is likely to be involved
in neurodegenerative disorders such as Alzheimer’sd i s -
ease [4]. Therefore, inhibition of BChE by using G.
Cambogia (Table 1) will not only produce better choli-
nergic transmission but also has the potential to inter-
fere with the disease process in Alzheimer’s disease and
other dementing disorders. This change raises the
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treatment for obesity and associated disorders.
There were normalization in nervous system which
indicated by inhibition of BChE activity in HFD+G com-
pared with HFD group (Table 1). This may be because
of super citrate max (HCA-SX) attenuate the increase in
oxidative stress by decreasing lipid peroxidation and
declining oxidative stress biomarkers in tissues [40].
It could be concluded that serum BChE activity is
increased in experimentally overweight rats and is asso-
ciated with biochemical parameters of adiposity while,
G. Cambogia ameliorated these changes.
4.5. Role of HFD and treatment on brain tissues oxidative
markers (catalase and MDA) in rats
In our experiment there was a significant increase in
brain catalase activity in HFD relative to control group
(Table 2). This change result from activation of bio-
chemical pathway leading to increased level of ROS and
amplified lipid peroxidation producing oxidative stress.
It appears that the modulation of antioxidant enzyme
activity plays a significant role in the initial elevations in
oxidative damage following HFD consumption.
The increment of brain catalase activity give evidence
for the relation between obesity, T2DM and oxidative
stress which agree with Houstis et al. [41] who reported
that insulin resistance accompanied by oxidative stress
indicated by increase ROS, moreover there are increased
superoxide potential, NADPH oxidase in obese patient.
Obesity result in metabolic syndrome this syndrome (e.g
T2DM) results form activation of biochemical pathway
leading to increased level of ROS and increased lipid
peroxidation generate oxidative stress.
Our data demonstrate that consumption of HFD for
12 weeks was adequate to increase the level of MDA as
marker of oxidative stress in the brains of rats (Table 2).
This change accompanied with significant hypercholes-
terolemia and hypertriglyceridemia which may be due to
HFD ingestion.
Brain MDA increased with obesity and positively corre-
lated with TG (P < 0.05 and r = 0.95), blood glucose (P <
0.007 and r = 0.99) and final BW (P < 0.03 and r = 0.91)
while, negatively correlated with NO (P < 0.05 and r =
-0.95), (Table 3) where MDA represented as indicator for
undesirable lipid peroxidation. Moreover, TG positively
correlated significantly with brain MDA, Catalase as indi-
cator of oxidative stress, suggesting association between
lipid peroxidation and brain biochemical alterations.
Oxidative stress and brain inflammation are thought
to play key roles in HFD-induced cognitive loss, as it
have been found to be increased in mice fed HFD which
show clear cognitive impairment [42].
There is increasing alertness of the everywhere role of
oxidative stress in neurobehavioral toxicity [43]. The
brain is vulnerable to oxidative stress damage because of
its high energy utilization, low levels of endogenous sca-
vengers (as vitamin C, catalase and superoxide dismu-
tase), high metabolic load, wide axonal and dendritic
networks, and high content of lipids, polyunsaturated
fatty acids and proteins [44]. Also the brain is a highly
vascularized renders it, extremely susceptible to undergo
rapid elevations in oxidative damage.
Consumption of HFD may promote lipid peroxidation
in the brain by elevating the levels of ROS, as has been
found in non-CNS tissues following consumption of a
HFD [26]. While the initial products of polyunsaturated
fatty acid oxidation are almost exclusively monohydro-
peroxides, these products are often rapidly put through
a progression of secondary and tertiary oxidative modifi-
cations that involve the genesis of lipid peroxyl and lipid
alkoxyl radicals. These increasingly toxic species are
capable of rapidly inducing a milieu of deleterious sig-
naling cascades, promoting disturbances in the plasma
membranes and inactivating vital cellular enzymatic
activities.
H o w e v e r ,b e c a u s et h ew h o l eb r a i nt i s s u ew a su t i l i z e d
in the current study, we may have missed the presence
of brain region specific elevations in oxidative stress. For
example, previous studies have demonstrated that a 4
month diet of a highly palatable diet selectively increases
oxidative stress in the rat frontal cortex [45]. Regardless,
the presence of elevated lipid peroxidation in this study
suggests that oxidative stress, via the elevation of poten-
tially toxic products such as lipid hydroperoxides, may
promote cellular stress and toxicity in the brain follow-
ing even the short-term consumption of a WD or HFD.
Studzinski et al., [46] found that short-term WD is
sufficient to selectively promote cerebral oxidative stress
and metabolic disturbances in mice, with increased oxi-
dative stress preceding alterations in Abeta. These data
have comparable and agreement to ours and have
important implications for understanding how WD or
HFD may potentially contribute to brain dysfunction
and the development of neurodegenerative disorders
such as Alzheimer’s disease.
H o w e v e r ,t h er o l eo fR O Si nt h eb r a i nh a sn o tb e e n
elucidated, although high dietary fat has been reported
to activate NADPH oxidase-derived increased oxidative
stress and inflammation in the brain [47]. Our viewpoint
that oxidative stress in the brain exerts an effect on cen-
tral sympathoexcitation in HFD-induced obesity is plau-
sible because recent studies have also implicated the
contribution of ROS overproduction in the brain for
activation of the sympathetic nervous system.
The current study raises the possibility of hyperglyce-
mia contributing to brain pathogenesis and altered brain
function via the generation of BOS. Similarly, other data
raise the possibility that circulating levels of adipokines
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neuroprotective role for adipokines emerging in a num-
ber of paradigms relevant to AD [48].
Taken together, our studies raise the possibility of diet
contributing to brain pathogenesis, via the generation of
cerebral oxidative stress. The current data have impor-
tant implications for understanding how diet and oxida-
tive stress may ultimately contribute to the development
of diet-related neurodegenerative disorders. We recom-
mended that BOS is an important initial factor for the
progression of brain pathology, with oxidative stress
potentially preceding the development of AD.
Clarifying the cellular mechanisms responsible for
increased levels of oxidative stress and identifying the
peripheral factors by which diet modulates cerebral oxi-
dative stress, will likely be a key to the development of
effective interventions to reverse or prevent the deleter-
ious effects of a HFD on the brain.
There were significant decreased in level of MDA in
HFD+G group (Table 2) compared with HFD group as
result of (-)hydroxy citric acid inhibit ATP citrate lyase
which catalyse extramitochondrial cleavage of citrate to
oxaloacetate to acetyl COA which used in fatty acid
synthesis and TC and TG synthesis. Moreover G. Cam-
bogia (HCA) has hypolipidemic action and there was
m a r k e dr e d u c t i o ni nM D Ab r a i nw h i c hw a sd u et o
effect of G. Cambogia that reduce MDA in tissues
which was recorded by Asghar et al. [40] indicating that
HCA improve lipid peroxidation.
It become noticeable that reduction of energy intake
decrease oxidative stress and diminish metabolic syn-
drome. In this concern G. Cambogia administration
affect on feed intake and appetite by increasing availabil-
ity of 5 hydroxy tryptamine and enhance serotonin in
brain that reduce appetite and inhibiting body fat bio-
synthesis [9]. Moreover super citrate max (HCA-SX)
attenuates the increase in oxidative stress [40]. These
findings consistent with our data where there were
reduction in catalase activity and significant MDA level
in HFD+G compared with HFD group indicating the
antioxidant effect of G. Cambogia.
It could be conclude that feeding HFD to rats increases
level of lipid profiles which consequently increase the level
of BOS and as a tissue toxicant accompanied with
increased activity of gGT, a-amylase, BChE, uric acids.
While using of G. Cambogia that contain hydroxyl citric
acid as antiobesity agent decrease TC, LDL which directly
affect MDA levels and improving brain dysfunction.
4-6- Role of diet induced obesity & treatment on brain
tissues NO level
Our data showed a significance decrease in NO brain
level in HFD (Table 2) compared with control group as
result of obesity and hypertriglyceridemia, this
decrement may be due to decreased bioavailability of
NO and reduce signaling of NO [49] that indicated by
reduced NO metabolite (nitrite and nitrate) production
within the brain tissue in HFD.
Obesity associated with hyperglycemia is a key factor
that contributes to the development of diabetes-related
microvascular disease, cyclooxygenase which lead to
increased oxidative stress and reduction in generation of
nitric oxide in microvessels endothelial cells [50].
Nitric oxide signaling involved in the regulation of
food intake and insulin signaling, is altered in obesity
and diabetes. Hyperglycemia impairs glucose and insulin
regulation of NO production where glucose inhibits NO
production which may occur through AMP-activated
protein kinase inhibition in ventromedial hypothalamus
neuron [51]. These findings supported by negative cor-
relation between glucose and brain NO (P < 0.024 and r
= -0.9) in HFD group (Table 3).
We found NO inactivation by ROS and functional NO
deficiency in our model which indicated by negative cor-
relation between NO and MDA oxidative stress in brain
tissues (P < 0.05 and r = -0.95) (Table 3). Also enhanced
ROS-mediated inactivation and sequestration of NO,
which may contribute to the reduction of bioactive NO
and dysregulation of NO synthesis isotype [52], given
the critical role of NO in BOS and function.
Concerning the relation of NO and BOS, a few research-
ers showed that exposure of rats to restraint stress sup-
pressed behavioral activity in the elevated plus maze and
this was associated with increases in brain MDA and
decrease in reduced glutathione and brain NO metabolite
levels in brain homogenates [53]. Moreover, Gulati et al.,
[54] reported that L-Arginine pretreatment was more
effective in modulating the restraint stress induced stress
responses/markers in the high emotional group of rats
and suggest that NO plays a differential role during expo-
sure to acute and repeated stress situations, and that the
relationship between stress and emotionality status may be
under the regulatory influence of NO.
Decrement of brain NO level in HFD group, initiate
vasoconstriction that affect brain and using methods for
controlling obesity suppose to increase NO level and
improving state of different organs that apparent in our
results due to action of nitric oxide as vasodilator. This
study provide persuasive evidence for the presence of
brain endothelial dysfunction in obesity which associated
with high abdominal fat, hyperglycemia, hypertriglyceri-
demia, hypercholesterolemia, abnormalities of LDL, high
BChE, gGT activity and brain oxidative stress as a
potential factors leading to endothelial dysfunction.
The current biochemical data (Table 2) suggest that
treatment with G. Cambogia has a protective effect on oxi-
dative stress induced alteration of brain oxidative injury in
HFD-rats and NO may be involved in this effect. In
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main signal molecule causing changes in enzyme activity
should be NO. NO synthetase activity from the HFD
group was decreased associated with diminished L-argi-
nine transport [55], consequently G. Cambogia decrease
TG leading to replenish the level of NO to normal.
The possibility that HFD associated with metabolic
disturbance and brain risk is alarming given interna-
tional trends of overweight and obesity in the general
population. However, prevention and manipulation of
adiposity may also provide a means to prevent AD.
Our data offer novel insights into potential mechan-
isms of brain dysfunction in obesity and the BChE and
gGT inhibition and NO elevation might represent a
novel strategy for the treatment of obesity with dyslipi-
demia and BOS, also demonstrate the efficacy of HCA
in weight management.
Conclusion
We could concluded that the mechanism by which HFD
could affect brain dysfunction is by rising obesity indica-
tors, lipid profile (TG, TC, LDL) and disturbing the meta-
bolic parameters (CK, gGT, uric acid and glucose in
blood) that correlated with BChE and associated with BOS
marker (brain MDA and catalase) and reduction of brain
NO resulting in brain lipid peroxidation, cerebrovascular
changes and consequently dysfunction and susceptible to
disease as AD while G. Cambogia as antiobesity and anti-
oxidant agent rearrange these changes.
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